EGFR and neoplasm: Downstream kinases of EGFR, including (but not limited to) the mitogen‐activated protein kinases (MAPKs) and PI3K‐Akt, are always hyperactive because of abnormal auto‐phosphorylation of EGFR in tumor tissue.